Skip to main content
. 2021 Aug 10;7(8):e07752. doi: 10.1016/j.heliyon.2021.e07752

Table 4.

Summary of ANOVA test for pharmacokinetic parameters following the administration of Treatment A and Treatment B.

Variables DF SS MS F -calculated P-value F-Critical

Formulation (Pan)






kel 1 0.040659 0.040659452 47.48512287 0.0000424093 4.964602701 S
t1/2 el 1 9.990031718 9.990032 24.57396416 0.000572387 4.964602701 S
AUC 0-24 1 1.942226 1.942225753 4.100431315 0.00785936 4.964602701 NS
AUC 0–∞ 1 1.8542499 1.8542499 3.898 0.120 4.964602701 NS
AUMC0–∞ 1 4433.437 4433.437033 3.414577326 0.094375974 4.964602701 NS
T max 1 0.009263 0.009262963 2.5 0.1449276 4.964602701 NS
C max 1 4.014852279 4.014852279 5.215636 0.048 4.964602701 S
Vd/F 1 28.80014 28.80014377 21.39541761 0.000942605 4.964602701 S
CL/F 1 60.76912 60.769122 10.03318166 0.010029824 4.964602701 S
K abs 1 32.66357 32.66356532 87.93778631 2.85561E-06 4.964602701 S
t 1/2 abs 1 0.0010279 0.0010279 48.039 0.002 4.964602701 S
MRT
1
0.128107
0.128106881
0.265808202
0.617362756
4.964602701
NS
Formulation (Ami)

k el 1 0.000195 0.0001952 4.792314491 0.053413976 4.964602701 NS
t1/2 el 1 25.09465 25.094651 2.184361437 0.213489081 4.964602701 NS
AUC 0-24 1 0.00016 0.0001598 0.68422833 0.42743197 4.964602701 NS
AUC 0–∞ 1 0.000214 0.0002139 0.565413106 0.469415754 4.964602701 NS
AUMC0–∞ 1 0.082142 0.0821424 0.171936615 0.687151419 4.964602701 NS
T max 1 0.705966 0.705966 4.106494527 0.070219993 4.964602701 NS
C max 1 0.001051 0.001051 23.53372713 0.000670214 4.964602701 S
Vd/F 1 1259.87 1259.8769 0.845427289 0.379494236 4.964602701 NS
CL/F 1 251.8523 251.85225 0.726044291 0.414109041 4.964602701 NS
K abs 1 267.7367 267.73671 12.05532912 0.006000196 4.964602701 S
t 1/2 abs 1 0.168785 0.1687854 9.659051581 0.011100273 4.964602701 S
MRT 1 3.223482 3.2234821 0.113052778 0.743643785 4.964602701 NS

DF: Degree of freedom, SS: Sum of Squares, MS: Mean of Squares, NS: Non significant difference, S: Significant difference.